VENAPERTA 4000 ANTI-XA IU/0.4 ML INJECTION SOLUTION IN READY-TO-USE SYRINGES (10 units) – 2026 Price Turkey

Clinical Data Review: Comprehensive profile for VENAPERTA 4000 ANTI-XA IU/0.4 ML INJECTION SOLUTION IN READY-TO-USE SYRINGES (10 units), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: VENAPERTA 4000 ANTI-XA IU/0.4 ML INJECTION SOLUTION IN READY-TO-USE SYRINGES (10 units)

Manufacturer: POLIFARMA PHARMACEUTICAL INDUSTRY AND TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

ENOKSAPARIN SODYUM 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

VENAPERTA 4000 ANTI-XA IU/0.4 ML INJECTION SOLUTION IN READY-TO-USE SYRINGES (10 units) is formulated with ENOKSAPARIN SODYUM, a clinically established agent in medical practice.

  • Mechanism of Action: ENOKSAPARIN SODYUM acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to ENOKSAPARIN SODYUM therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name VENAPERTA 4000 ANTI-XA IU/0.4 ML INJECTION SOLUTION IN READY-TO-USE SYRINGES (10 units)
Barcode (GTIN) 8699606954750
Generic Name ENOKSAPARIN SODYUM
License Holder POLIFARMA PHARMACEUTICAL INDUSTRY AND TRADE INC.
Pharmacy Retail Price 1248.44 TL
⚠️ Clinical Safety Warning

Do not administer VENAPERTA 4000 ANTI-XA IU/0.4 ML INJECTION SOLUTION IN READY-TO-USE SYRINGES (10 units) if the patient has a known hypersensitivity or allergy to ENOKSAPARIN SODYUM. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.


Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via POLIFARMA PHARMACEUTICAL INDUSTRY AND TRADE INC..

Leave a Comment